Both in Pharmaceuticals
Climb Bio vs PUMA BIOTECHNOLOGY
Over the past year CLYM returned +370.5% and PBYI returned +102.0%; their daily moves had a correlation of 0.20.
CLYM +370.5% PBYI +102.0%Growth of $1, one year, split-adjusted
| Metric | CLYM | PBYI |
|---|---|---|
| Price | $9.88 | $10.65 |
| Market cap | $567.5M | $549.5M |
| Today | +3.24% | −2.52% |
| 1 month | −14.1% | +8.8% |
| 6 months | +12.5% | +42.3% |
| Year to date | +147.0% | +78.9% |
| 1 year | +370.5% | +102.0% |
| Revenue growth (YoY) | — | +7.8% |
| Gross margin | — | 77.9% |
| Net margin | — | 14.5% |
| P/E (TTM) | — | 20.6× |
| Price / sales | — | 2.4× |
| Net cash | $183.1M | $93.9M |
| Dividend yield | — | — |
| Volatility (60d) | 83.3% | 43.6% |
| Short % of float | 25.6% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).